Literature DB >> 30543462

Liver repair and regeneration after ischemia-reperfusion injury is associated with prolonged fibrosis.

Takanori Konishi1, Rebecca M Schuster1, Alex B Lentsch1.   

Abstract

Liver recovery after hepatic ischemia-reperfusion (I/R) injury is characterized by clearance of dead tissue and its replacement with functional liver parenchyma. Previous reports have observed fibrosis after liver I/R. To determine whether liver fibrosis after I/R was a pathologic consequence of the injury response, we assessed the development of liver fibrosis after I/R and its impact on subsequent insult. A murine model of partial I/R was used to induce liver injury and study the reparative response. During liver remodeling after I/R, expression of the profibrotic genes increased in the ischemic liver. Histologically, α-smooth muscle actin (α-SMA)-positive hepatic stellate cells (HSCs)/myofibroblasts increased, and collagen deposition was enhanced along the injured site. Selective staining experiments showed that HSCs, not portal fibroblasts, were the major source of myofibroblasts. During liver repair after I/R, liver fibrosis was readily observed at the interface between necrotic tissue and regenerating liver in association with HSCs/myofibroblasts. The number of HSCs/myofibroblasts decreasing shortly after the full resolution of necrotic injury and restoration are normal liver architecture. However, liver fibrosis persisted for several more weeks before gradually resolving. Resolution of liver fibrosis was accompanied by upregulated expression of matrix metalloproteinase-13. After resolution of fibrosis, the administration of CCl4 did not result in exacerbated liver injury, suggesting that I/R injury does not predispose the liver to future fibrotic insults. The data suggest that liver fibrosis is a component of tissue repair after I/R, is caused by myofibroblasts derived from HSC, and does not increase susceptibility of the liver to subsequent hepatic injury. NEW & NOTEWORTHY This study is the first to assess pathology of liver fibrosis during the reparative process after ischemia-reperfusion (I/R) injury. Here we show that profibrotic gene expression increased in the liver after I/R, and collagen accumulation produced by hepatic stellate cells (HSCs)/myofibroblasts enhanced at the interface between necrotic tissue and regenerating liver. Liver fibrosis gradually resolved concomitant with decreasing activation of HSC and upregulating matrix metalloproteinase-13. After resolution of fibrosis, the liver was not more susceptible to subsequent hepatic injury.

Entities:  

Keywords:  hepatic stellate cells; liver fibrosis; liver regeneration; liver repair

Mesh:

Year:  2018        PMID: 30543462      PMCID: PMC6459287          DOI: 10.1152/ajpgi.00154.2018

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  7 in total

1.  Liver Ischemia and Reperfusion Induce Periportal Expression of Necroptosis Executor pMLKL Which Is Associated With Early Allograft Dysfunction After Transplantation.

Authors:  Shaojun Shi; Eliano Bonaccorsi-Riani; Ivo Schurink; Thierry van den Bosch; Michael Doukas; Karishma A Lila; Henk P Roest; Daela Xhema; Pierre Gianello; Jeroen de Jonge; Monique M A Verstegen; Luc J W van der Laan
Journal:  Front Immunol       Date:  2022-05-17       Impact factor: 8.786

2.  Fibrotic liver has prompt recovery after ischemia-reperfusion injury.

Authors:  Takanori Konishi; Rebecca M Schuster; Holly S Goetzman; Charles C Caldwell; Alex B Lentsch
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-21       Impact factor: 4.052

3.  Propofol Protects Against Hepatic Ischemia Reperfusion Injury via Inhibiting Bnip3-Mediated Oxidative Stress.

Authors:  Hongyan Ma; Ying Liu; Zhengtian Li; Lu Yu; Yang Gao; Xiangmei Ye; Baoyi Yang; Hulun Li; Jinghui Shi
Journal:  Inflammation       Date:  2021-01-26       Impact factor: 4.092

Review 4.  Cellular origins of regenerating liver and hepatocellular carcinoma.

Authors:  Ágnes Holczbauer; Kirk J Wangensteen; Soona Shin
Journal:  JHEP Rep       Date:  2021-12-13

5.  Precision Navigation of Hepatic Ischemia-Reperfusion Injury Guided by Lysosomal Viscosity-Activatable NIR-II Fluorescence.

Authors:  Jihong Liu; Wen Zhang; Chunmiao Zhou; Mengmei Li; Xin Wang; Wei Zhang; Zhenzhen Liu; Luling Wu; Tony D James; Ping Li; Bo Tang
Journal:  J Am Chem Soc       Date:  2022-07-06       Impact factor: 16.383

Review 6.  Role of hepatic stellate cells in liver ischemia-reperfusion injury.

Authors:  Yuming Peng; Qiang Yin; Miaoxian Yuan; Lijian Chen; Xinyi Shen; Weixin Xie; Jinqiao Liu
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

7.  Monoacylglycerol Acyltransferase 1 Knockdown Exacerbates Hepatic Ischemia/Reperfusion Injury in Mice With Hepatic Steatosis.

Authors:  Kim H H Liss; Shelby E Ek; Andrew J Lutkewitte; Terri A Pietka; Mai He; Priya Skaria; Eric Tycksen; Daniel Ferguson; Valerie Blanc; Mark J Graham; Angela M Hall; Mitchell R McGill; Kyle S McCommis; Brian N Finck
Journal:  Liver Transpl       Date:  2020-10-22       Impact factor: 5.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.